| Andrea M Granzin, OT | |
|
181 W Meadow Dr, Vail, CO 81657-5242 | |
| (971) 479-7275 | |
| Not Available |
| Full Name | Andrea M Granzin |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 20 Years |
| Location | 181 W Meadow Dr, Vail, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497022065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2150 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vail Clinic Inc | 3577475714 | 164 |
News Archive
Mahul B. Amin, MD, chair of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, will offer his perspectives and expertise on personalized medicine and digital pathology at the 2011 Pathology Visions Conference.
"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."
A bacterium known for causing stomach cancer might also increase the risk of certain colorectal cancers, particularly among African Americans, according to a study led by Duke Cancer Institute researchers.
In rooms of patients with multidrug-resistant organisms, the outside of the packages containing sterile items can become contaminated.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.
› Verified 7 days ago
| Provider Name | Vail Clinic Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1992812333 PECOS PAC ID: 3577475714 Enrollment ID: O20031105000224 |
News Archive
Mahul B. Amin, MD, chair of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, will offer his perspectives and expertise on personalized medicine and digital pathology at the 2011 Pathology Visions Conference.
"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."
A bacterium known for causing stomach cancer might also increase the risk of certain colorectal cancers, particularly among African Americans, according to a study led by Duke Cancer Institute researchers.
In rooms of patients with multidrug-resistant organisms, the outside of the packages containing sterile items can become contaminated.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea M Granzin, OT Po Box 40000, Vail, CO 81658-7520 Ph: (971) 479-7275 | Andrea M Granzin, OT 181 W Meadow Dr, Vail, CO 81657-5242 Ph: (971) 479-7275 |
News Archive
Mahul B. Amin, MD, chair of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, will offer his perspectives and expertise on personalized medicine and digital pathology at the 2011 Pathology Visions Conference.
"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."
A bacterium known for causing stomach cancer might also increase the risk of certain colorectal cancers, particularly among African Americans, according to a study led by Duke Cancer Institute researchers.
In rooms of patients with multidrug-resistant organisms, the outside of the packages containing sterile items can become contaminated.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.
› Verified 7 days ago
Mary L Leone, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 181 So Frontage Road West, Vail, CO 81657 Phone: 970-668-3169 Fax: 970-668-3243 | |
Ms. Isabelle C Sunderland, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 180 S Frontage Rd W, Vail, CO 81657 Phone: 970-476-1225 | |
Holly Coulson, OTR/L CHT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 181 W Meadow Dr, Vail, CO 81657 Phone: 970-476-1225 | |
Emily Elizabeth Micho, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 181 W Meadow Dr, Vail, CO 81657 Phone: 970-476-2451 | |
Kathi A Thomson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 181 W Meadow Dr, Vail, CO 81657 Phone: 970-479-7275 | |
Emily Ryon, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 181 W Meadow Dr, Vail, CO 81657 Phone: 970-476-2451 |